Stockscreener 앱 받기
14.36
4.66%
0.615
Minimed Group Inc 주식(MMED)의 최신 뉴스
MiniMed rolls out Abbott’s 15-day Instinct sensors across Europe - Stock Titan
This Undervalued Medical-Devices Stock Is Poised for a Rebound - Barron's
MiniMed Group (MMED) Stock Forecast and Price Target 2026 - MarketBeat
A Quick Look at Today's Ratings for MiniMed Group(MMED.US), With a Forecast Between $16 to $25 - Moomoo
Is Medtronic's MiniMed Spin-Off a Smart Bet for Investors - Kavout
MiniMed’s smallest insulin pump is now on sale in the U.S. - Stock Titan
William Blair Initiates MiniMed Group(MMED.US) With Buy Rating - Moomoo
MMED Q1 2026 Earnings: EPS Falls Far Short of EstimatesLow Growth Earnings - newsline.com
Benchmark reiterates MiniMed Group stock rating on product launches By Investing.com - Investing.com Canada
MMED Price Today: MiniMed Group, Inc. Stock Price, Quote & Chart | MEXC - MEXC
MMED's latest study supports the strength of 780G SmartGuard algorithm - MSN
Wells Fargo Maintains MiniMed Group(MMED.US) With Buy Rating, Raises Target Price to $26 - Moomoo
MiniMed Group (MMED) Short Interest & Short Float | Updated Jun 2026 - MarketBeat
MiniMed Group Inc. (MMED) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
A Look At MiniMed Group (MMED) Valuation After Recent Share Price Volatility - Yahoo Finance
MiniMed Group (MMED) Goldman Sachs 47th Annual Global Healthcare Conference 2026 summary - Quartr
BofA Securities Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Evercore Maintains MiniMed Group(MMED.US) With Buy Rating, Maintains Target Price $20 - Moomoo
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 - Investing.com
Piper Sandler reiterates Neutral rating on MiniMed stock at $16 By Investing.com - Investing.com India
MiniMed Fiscal Q4 Loss Unchanged, Revenue Rises; Shares Up Pre-Bell - Moomoo
MiniMed Closes FY26 On A Strong Note, Eyes Long-Term Growth - RTTNews
MiniMed (MMED) Reports Strong Q4 Revenue Growth - GuruFocus
Minimed Group Inc (MMED) Q4 2025 Earnings Call Highlights: Record Revenue and Strategic Product ... By GuruFocus - Investing.com Canada
MMED Projects 16% Adjusted EBITDA Margin by FY27 - GuruFocus
Why Medtronic Stock Popped Today - Yahoo Finance
MiniMed Group Inc. (MMED) Surges 12.93% as Bulls Test Key Resistance LevelStock Buy Zone - newsline.com
Navitas Semiconductor, Abivax, MiniMed And Other Big Stocks Moving Higher On Wednesday - Benzinga
MiniMed Stock Surges 11% to $13.69 After Strong Q4 Results and Bullish 2027 Outlook - International Business Times Australia
MMED: Record revenue, robust pipeline, and 10% organic growth outlook for FY 2027 - TradingView
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises By Investing.com - Investing.com South Africa
MiniMed Group Q4 Earnings Call Highlights - MarketBeat
Earnings call transcript: MiniMed sees strong Q4 2026 growth, stock rises - Investing.com
MMED: Record revenue, robust pipeline, and 10% growth outlook highlight strong momentum - TradingView
MiniMed Shares Rise on 4Q Sales, Abbott Partnership Expansion - marketscreener.com
Full Transcript: Minimed Group Q4 2026 Earnings Call - Benzinga
MiniMed Group Q4 2026 Earnings Call Transcript - MarketBeat
MiniMed Group, Inc. Reports Earnings Results for the Fourth Quarter Ended April 24, 2026 - marketscreener.com
Medtronic reports fourth quarter and full year fiscal 2026 results; delivers highest annual revenue growth in 10 years - Medtronic
MMED: FY26 revenue surpassed $3B with strong growth and FY27 guidance targets further margin expansion - TradingView
Minimed: Fiscal Q4 Earnings Snapshot - marketscreener.com
Earnings Flash (MMED) MiniMed Reports Q4 Revenue $837.0M, vs. FactSet Est of $827.9M - marketscreener.com
MiniMed partners with Abbott on dual glucose-ketone sensors By Investing.com - Investing.com Canada
MMED: Record $3B+ sales, strong international growth, and FY27 guidance for 10% organic revenue growth - TradingView
MiniMed (MMED) grows revenue to $3.1B in FY 2026 but widens loss - Stock Titan
MiniMed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott - marketscreener.com
MiniMed Delivers Strong Fourth Quarter and Full Fiscal Year 2026 Financial Results; Provides Fiscal Year 2027 Outlook - marketscreener.com
New diabetes sensor tracks ketones to spot DKA risk earlier - Stock Titan
Diabetes tech firm MiniMed tops $3.1B sales, sees 10% organic growth in FY27 - Stock Titan
Minimed to Expand Sensor Portfolio with Integrated Dual Glucose-Ketone Sensors Made by Abbott - marketscreener.com
3.86%
자본화:
|
볼륨(24시간):